Flurbiprofen	flurbiprofen	O	O	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
treatment	treatment	O	O	O	O
of	of	O	O	O	O
juvenile	juvenile	O	O	OTHERS	I
rheumatoid	rheumatoid	O	DISEASE	OTHERS	I
arthritis	arthritis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Thirty-four	thirty-four	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
juvenile	juvenile	O	O	OTHERS	I
rheumatoid	rheumatoid	O	DISEASE	OTHERS	I
arthritis	arthritis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
who	who	O	O	O	O
were	were	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
flurbiprofen	flurbiprofen	O	O	OTHERS	I
at	at	O	O	O	O
a	a	O	O	O	O
maximum	maximum	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
4	4	O	O	O	O
mg/kg/day	mg/kg/day	O	O	O	O
,	,	O	O	O	O
had	had	O	O	O	O
statistically	statistically	O	O	O	O
significant	significant	O	O	O	O
decreases	decreases	O	O	O	O
from	from	O	O	O	O
baseline	baseline	O	O	O	O
in	in	O	O	O	O
6	6	O	O	O	O
arthritis	arthritis	O	DISEASE	OTHERS	I
indices	indices	O	O	O	O
after	after	O	O	O	O
12	12	O	O	O	O
weeks	weeks	O	O	O	O
of	of	O	O	O	O
treatment	treatment	O	O	O	O
.	.	O	O	O	O

Improvements	improvements	O	O	O	O
were	were	O	O	O	O
seen	seen	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
number	number	O	O	O	O
of	of	O	O	O	O
tender	tender	O	O	OTHERS	I
joints	joints	O	O	OTHERS	I
,	,	O	O	O	O
the	the	O	O	O	O
severity	severity	O	O	O	O
of	of	O	O	O	O
swelling	swelling	O	O	OTHERS	I
and	and	O	O	O	O
tenderness	tenderness	O	O	OTHERS	I
,	,	O	O	O	O
the	the	O	O	O	O
time	time	O	O	O	O
of	of	O	O	O	O
walk	walk	O	O	O	O
50	50	O	O	O	O
feet	feet	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
duration	duration	O	O	O	O
of	of	O	O	O	O
morning	morning	O	O	OTHERS	I
stiffness	stiffness	O	O	OTHERS	I
and	and	O	O	O	O
the	the	O	O	O	O
circumference	circumference	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
left	left	O	O	O	O
knee	knee	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
most	most	O	O	O	O
frequently	frequently	O	O	O	O
observed	observed	O	O	O	O
side	side	O	O	O	O
effect	effect	O	O	O	O
was	was	O	O	O	O
fecal	fecal	O	O	OTHERS	I
occult	occult	O	O	OTHERS	I
blood	blood	O	O	OTHERS	I
(	(	O	O	O	O
25	25	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
patients	patients	O	O	O	O
)	)	O	O	O	O
;	;	O	O	O	O
however	however	O	O	O	O
,	,	O	O	O	O
there	there	O	O	O	O
was	was	O	O	O	O
no	no	O	O	O	O
other	other	O	O	O	O
evidence	evidence	O	O	O	O
of	of	O	O	O	O
gastrointestinal	gastrointestinal	O	O	OTHERS	I
(	(	O	O	OTHERS	I
GI	gi	O	O	OTHERS	I
)	)	O	O	OTHERS	I
bleeding	bleeding	O	DISEASE	OTHERS	I
in	in	O	O	O	O
these	these	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

One	one	O	O	O	O
patient	patient	O	O	O	O
was	was	O	O	O	O
prematurely	prematurely	O	O	O	O
discontinued	discontinued	O	O	O	O
from	from	O	O	O	O
the	the	O	O	O	O
study	study	O	O	O	O
for	for	O	O	O	O
severe	severe	O	O	O	O
headache	headache	O	DISEASE	OTHERS	I
and	and	O	O	O	O
abdominal	abdominal	O	DISEASE	OTHERS	I
pain	pain	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Most	most	O	O	O	O
side	side	O	O	O	O
effects	effects	O	O	O	O
were	were	O	O	O	O
mild	mild	O	O	O	O
and	and	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
GI	gi	O	O	O	O
tract	tract	O	O	O	O
.	.	O	O	O	O

